Integer Holdings Corporation
General ticker "ITGR" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $4.0B (TTM average)
Integer Holdings Corporation does not follow the US Stock Market performance with the rate: -24.9%.
Estimated limits based on current volatility of 1.2%: low 84.69$, high 86.81$
Factors to consider:
- Total employees count: 11000 as of 2024
- US accounted for 54.7% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Customer dependency, Supply chain disruptions, Cybersecurity threats, Integration challenges, Operational and conduct risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [57.76$, 95.40$]
- 2026-12-31 to 2027-12-31 estimated range: [56.33$, 91.69$]
Financial Metrics affecting the ITGR estimates:
- Negative: with PPE of 12.2 at the end of fiscal year the price was high
- Positive: 7.67 < Operating profit margin, % of 12.93
- Positive: 6.64 < Operating cash flow per share per price, % of 7.23
- Negative: Industry earnings per price (median), % of -1.91 <= 0
- Negative: negative Industry operating income (median)
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 1.59 <= 3.28
- Positive: Inventory ratio change, % of -0.56 <= 0
- Negative: Industry inventory ratio change (median), % of 0.58 > 0.31
Short-term ITGR quotes
Long-term ITGR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,555.66MM | $1,716.60MM | $1,853.64MM |
| Operating Expenses | $1,392.33MM | $1,508.36MM | $1,614.02MM |
| Operating Income | $163.32MM | $208.24MM | $239.62MM |
| Non-Operating Income | $-57.94MM | $-60.67MM | $-114.23MM |
| Interest Expense | $51.27MM | $56.37MM | $43.21MM |
| R&D Expense | $61.97MM | $53.42MM | $49.50MM |
| Income(Loss) | $105.38MM | $147.56MM | $125.40MM |
| Taxes | $16.24MM | $26.51MM | $22.57MM |
| Other Income(Loss) | $1.51MM | $-1.16MM | $0.00MM |
| Profit(Loss)* | $92.16MM | $121.05MM | $102.81MM |
| Stockholders Equity | $1,519.04MM | $1,619.21MM | $1,746.64MM |
| Inventory | $229.10MM | $247.13MM | $253.74MM |
| Assets | $2,942.65MM | $3,077.97MM | $3,410.58MM |
| Operating Cash Flow | $180.21MM | $205.21MM | $196.15MM |
| Capital expenditure | $119.94MM | $105.61MM | $91.03MM |
| Investing Cash Flow | $-163.37MM | $-195.41MM | $-270.73MM |
| Financing Cash Flow | $-18.01MM | $13.32MM | $43.56MM |
| Earnings Per Share** | $2.77 | $3.60 | $2.96 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.